OTC Pharmaceuticals - Sudan

Sudan

Revenue in the OTC Pharmaceuticals market amounts to US$99.19m in 2024. The market is expected to grow annually by -2.45% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$34.50m in 2024.
In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
In relation to total population figures, per person revenues of US$2.01 are generated in 2024.
In the OTC Pharmaceuticals market, 0.7% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Sudan has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences in Sudan have shifted towards self-medication and the use of over-the-counter (OTC) pharmaceuticals. This can be attributed to several factors, including increased awareness and education about health and wellness, as well as the convenience and accessibility of OTC products. Consumers in Sudan are increasingly seeking quick and affordable solutions for common ailments, and OTC pharmaceuticals provide a viable option.

Trends in the OTC Pharmaceuticals market in Sudan reflect global and regional patterns. There has been a growing demand for products that address common health issues such as pain relief, cough and cold, and digestive problems. This is in line with the overall trend of self-care and preventive healthcare, as consumers are taking proactive measures to maintain their wellbeing.

Additionally, there has been an increase in the availability and variety of OTC pharmaceutical products in Sudan, with both local and international brands entering the market to cater to the growing demand. Local special circumstances in Sudan have also played a role in the development of the OTC Pharmaceuticals market. The country has a large population with limited access to healthcare facilities, particularly in rural areas.

This has created a need for easily accessible and affordable healthcare solutions, which OTC pharmaceuticals can provide. Additionally, the ongoing economic challenges in Sudan have led to a decrease in disposable income for many individuals, making OTC products a more affordable option compared to prescription medications. Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Sudan.

The country has been experiencing economic reforms and increased foreign investment, which has led to improvements in infrastructure and healthcare services. This has created a favorable environment for the expansion of the OTC Pharmaceuticals market. Furthermore, the government has implemented policies to promote the local manufacturing of pharmaceutical products, which has led to increased production and availability of OTC drugs in the country.

In conclusion, the OTC Pharmaceuticals market in Sudan is developing due to customer preferences for self-medication, global and regional trends towards preventive healthcare, local special circumstances such as limited access to healthcare facilities, and underlying macroeconomic factors including economic reforms and government policies. The market is expected to continue growing as consumers increasingly prioritize their health and seek affordable and accessible healthcare solutions.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.